Publicaciones en las que colabora con GRACIA MERINO PELÁEZ (39)

2016

  1. Effect of bovine ABCG2 Y581S polymorphism on concentrations in milk of enrofloxacin and its active metabolite ciprofloxacin

    Journal of Dairy Science, Vol. 99, Núm. 7, pp. 5731-5738

  2. Effect of bovine ABCG2 polymorphism Y581S SNP on secretion into milk of enterolactone, riboflavin and uric acid

    Animal, Vol. 10, Núm. 2, pp. 238-247

2015

  1. ABCG2/BCRP interaction with the sea grass Thalassia testudinum

    Drug Metabolism and Personalized Therapy, Vol. 30, Núm. 4, pp. 251-256

  2. Short communication: The gain-of-function Y581S polymorphism of the ABCG2 transporter increases secretion into milk of danofloxacin at the therapeutic dose for mastitis treatment

    Journal of Dairy Science, Vol. 98, Núm. 1, pp. 312-317

2014

  1. Novel in vitro systems for prediction of veterinary drug residues in ovine milk and dairy products

    Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment, Vol. 31, Núm. 6, pp. 1026-1037

  2. Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain

    Pharmacological Research, Vol. 87, pp. 87-93

2013

  1. Effects of triclabendazole on secretion of danofloxacin and moxidectin into the milk of sheep: Role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporter

    Veterinary Journal, Vol. 198, Núm. 2, pp. 429-436

  2. Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: Effect on plasma and milk levels of danofloxacin in sheep

    Veterinary Journal, Vol. 196, Núm. 2, pp. 203-208

  3. The bovine atp-binding cassette transporter abcg2 tyr581ser single-nucleotide polymorphism increases milk secretion of the fluoroquinolone danofloxacin

    Drug Metabolism and Disposition, Vol. 41, Núm. 3, pp. 546-549

2012

  1. Reevaluation of the roles of ABCG2 in the disposition of genistein

    Drug Metabolism and Disposition

  2. The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 7, pp. 3535-3543

2011

  1. Analysis of the effect of the bovine adenosine triphosphate-binding cassette transporter G2 single nucleotide polymorphism Y581S on transcellular transport of veterinary drugs using new cell culture models

    Journal of Animal Science, Vol. 89, Núm. 12, pp. 4325-4338

  2. Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice

    Drug Metabolism and Disposition, Vol. 39, Núm. 11, pp. 2008-2012

  3. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: Interaction with ivermectin

    Journal of Veterinary Pharmacology and Therapeutics, Vol. 34, Núm. 4, pp. 313-321

2010

  1. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C

    European Journal of Pharmacology, Vol. 644, Núm. 1-3, pp. 41-48

  2. In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: A comparative study in Bcrp1 -/- mice

    Pharmaceutical Research, Vol. 27, Núm. 10, pp. 2098-2105

  3. Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans- resveratrol in knockout mice

    Journal of Agricultural and Food Chemistry, Vol. 58, Núm. 7, pp. 4523-4528

  4. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response

    Journal of Pharmaceutical Sciences, Vol. 99, Núm. 2, pp. 598-617

2009

  1. Antioxidant profile of hyaluronan: Physico-chemical features and its role in pathologies

    Mini-Reviews in Medicinal Chemistry

  2. In vitro and in vivo interaction of moxidectin with BCRP/ABCG2

    Chemico-Biological Interactions, Vol. 180, Núm. 1, pp. 106-112